ビンブラスチン硫酸塩のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Vinblastinesulphate Market Insights and Forecast to 2028

• レポートコード：QY2203B05251 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のビンブラスチン硫酸塩の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にビンブラスチン硫酸塩の世界市場のxxx％を占める「>98％ビンブラスチン硫酸塩」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「リンパ腫」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のビンブラスチン硫酸塩の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのビンブラスチン硫酸塩市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのビンブラスチン硫酸塩市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ビンブラスチン硫酸塩のグローバル主要メーカーには、Guangzhou Hanfang Pharmaceutical、Hainan Vinca Biological Medicine Technology、Guangzhou Person Pharmaceutical、Hainan Yueyang Biotechnology、Hubei Honch Pharmaceutical、Fine Chemicals Corporation、Hengtengfu Biological Products、Vinkemなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ビンブラスチン硫酸塩市場は、種類と用途によって区分されます。世界のビンブラスチン硫酸塩市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 >98％ビンブラスチン硫酸塩、97～98％ビンブラスチン硫酸塩、その他 【用途別セグメント】 リンパ腫、肺がん、乳がん・卵巣がん、白血病、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ビンブラスチン硫酸塩製品概要 - 種類別市場（>98％ビンブラスチン硫酸塩、97～98％ビンブラスチン硫酸塩、その他） - 用途別市場（リンパ腫、肺がん、乳がん・卵巣がん、白血病、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のビンブラスチン硫酸塩販売量予測2017-2028 - 世界のビンブラスチン硫酸塩売上予測2017-2028 - ビンブラスチン硫酸塩の地域別販売量 - ビンブラスチン硫酸塩の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ビンブラスチン硫酸塩販売量 - 主要メーカー別ビンブラスチン硫酸塩売上 - 主要メーカー別ビンブラスチン硫酸塩価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（>98％ビンブラスチン硫酸塩、97～98％ビンブラスチン硫酸塩、その他） - ビンブラスチン硫酸塩の種類別販売量 - ビンブラスチン硫酸塩の種類別売上 - ビンブラスチン硫酸塩の種類別価格 ・用途別市場規模（リンパ腫、肺がん、乳がん・卵巣がん、白血病、その他） - ビンブラスチン硫酸塩の用途別販売量 - ビンブラスチン硫酸塩の用途別売上 - ビンブラスチン硫酸塩の用途別価格 ・北米市場 - 北米のビンブラスチン硫酸塩市場規模（種類別、用途別） - 主要国別のビンブラスチン硫酸塩市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのビンブラスチン硫酸塩市場規模（種類別、用途別） - 主要国別のビンブラスチン硫酸塩市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のビンブラスチン硫酸塩市場規模（種類別、用途別） - 主要国別のビンブラスチン硫酸塩市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のビンブラスチン硫酸塩市場規模（種類別、用途別） - 主要国別のビンブラスチン硫酸塩市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのビンブラスチン硫酸塩市場規模（種類別、用途別） - 主要国別のビンブラスチン硫酸塩市場規模（トルコ、サウジアラビア） ・企業情報 Guangzhou Hanfang Pharmaceutical、Hainan Vinca Biological Medicine Technology、Guangzhou Person Pharmaceutical、Hainan Yueyang Biotechnology、Hubei Honch Pharmaceutical、Fine Chemicals Corporation、Hengtengfu Biological Products、Vinkem ・産業チェーン及び販売チャネル分析 - ビンブラスチン硫酸塩の産業チェーン分析 - ビンブラスチン硫酸塩の原材料 - ビンブラスチン硫酸塩の生産プロセス - ビンブラスチン硫酸塩の販売及びマーケティング - ビンブラスチン硫酸塩の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ビンブラスチン硫酸塩の産業動向 - ビンブラスチン硫酸塩のマーケットドライバー - ビンブラスチン硫酸塩の課題 - ビンブラスチン硫酸塩の阻害要因 ・主な調査結果

Vinblastinesulphate (CAS 143-67-9) is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin’s disease, non-Hodgkin’s lymphoma (cancer of the lymph cells), Kaposi’s sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.
Market Analysis and Insights: Global Vinblastinesulphate Market
Due to the COVID-19 pandemic, the global Vinblastinesulphate market size is estimated to be worth US$ 22 million in 2022 and is forecast to a readjusted size of US$ 24 million by 2028 with a CAGR of 1.1% during the review period. Fully considering the economic change by this health crisis, >98% Vinblastinesulphate accounting for % of the Vinblastinesulphate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Lymphoma segment is altered to an % CAGR throughout this forecast period.
Global Vinblastinesulphate (CAS 143-67-9) key players include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, etc. Global top four manufacturers hold a share about 60%.
China is the largest market, with a share about 40%, followed by Europe and USA, have a share over 40 percent.
In terms of product, 97-98% Vinblastinesulphate is the largest segment, with a share about 60%. And in terms of application, the largest application is Lymphoma, followed by Lung Cancer, Breast & Ovarian Cancer, Leukemia, ect.
In terms of production side, this report researches the Vinblastinesulphate capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Vinblastinesulphate by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Vinblastinesulphate Scope and Segment
Vinblastinesulphate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vinblastinesulphate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
>98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Segment by Application
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
By Company
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Production by Region
South Africa
India
China
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Vinblastinesulphate Product Introduction
1.2 Market by Type
1.2.1 Global Vinblastinesulphate Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 >98% Vinblastinesulphate
1.2.3 97-98% Vinblastinesulphate
1.2.4 Other
1.3 Market by Application
1.3.1 Global Vinblastinesulphate Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Lung Cancer
1.3.4 Breast & Ovarian Cancer
1.3.5 Leukemia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Vinblastinesulphate Production
2.1 Global Vinblastinesulphate Production Capacity (2017-2028)
2.2 Global Vinblastinesulphate Production by Region: 2017 VS 2021 VS 2028
2.3 Global Vinblastinesulphate Production by Region
2.3.1 Global Vinblastinesulphate Historic Production by Region (2017-2022)
2.3.2 Global Vinblastinesulphate Forecasted Production by Region (2023-2028)
2.4 South Africa
2.5 India
2.6 China
3 Global Vinblastinesulphate Sales in Volume & Value Estimates and Forecasts
3.1 Global Vinblastinesulphate Sales Estimates and Forecasts 2017-2028
3.2 Global Vinblastinesulphate Revenue Estimates and Forecasts 2017-2028
3.3 Global Vinblastinesulphate Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Vinblastinesulphate Sales by Region
3.4.1 Global Vinblastinesulphate Sales by Region (2017-2022)
3.4.2 Global Sales Vinblastinesulphate by Region (2023-2028)
3.5 Global Vinblastinesulphate Revenue by Region
3.5.1 Global Vinblastinesulphate Revenue by Region (2017-2022)
3.5.2 Global Vinblastinesulphate Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Vinblastinesulphate Production Capacity by Manufacturers
4.2 Global Vinblastinesulphate Sales by Manufacturers
4.2.1 Global Vinblastinesulphate Sales by Manufacturers (2017-2022)
4.2.2 Global Vinblastinesulphate Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Vinblastinesulphate in 2021
4.3 Global Vinblastinesulphate Revenue by Manufacturers
4.3.1 Global Vinblastinesulphate Revenue by Manufacturers (2017-2022)
4.3.2 Global Vinblastinesulphate Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Vinblastinesulphate Revenue in 2021
4.4 Global Vinblastinesulphate Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Vinblastinesulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Vinblastinesulphate Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Vinblastinesulphate Sales by Type
5.1.1 Global Vinblastinesulphate Historical Sales by Type (2017-2022)
5.1.2 Global Vinblastinesulphate Forecasted Sales by Type (2023-2028)
5.1.3 Global Vinblastinesulphate Sales Market Share by Type (2017-2028)
5.2 Global Vinblastinesulphate Revenue by Type
5.2.1 Global Vinblastinesulphate Historical Revenue by Type (2017-2022)
5.2.2 Global Vinblastinesulphate Forecasted Revenue by Type (2023-2028)
5.2.3 Global Vinblastinesulphate Revenue Market Share by Type (2017-2028)
5.3 Global Vinblastinesulphate Price by Type
5.3.1 Global Vinblastinesulphate Price by Type (2017-2022)
5.3.2 Global Vinblastinesulphate Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Vinblastinesulphate Sales by Application
6.1.1 Global Vinblastinesulphate Historical Sales by Application (2017-2022)
6.1.2 Global Vinblastinesulphate Forecasted Sales by Application (2023-2028)
6.1.3 Global Vinblastinesulphate Sales Market Share by Application (2017-2028)
6.2 Global Vinblastinesulphate Revenue by Application
6.2.1 Global Vinblastinesulphate Historical Revenue by Application (2017-2022)
6.2.2 Global Vinblastinesulphate Forecasted Revenue by Application (2023-2028)
6.2.3 Global Vinblastinesulphate Revenue Market Share by Application (2017-2028)
6.3 Global Vinblastinesulphate Price by Application
6.3.1 Global Vinblastinesulphate Price by Application (2017-2022)
6.3.2 Global Vinblastinesulphate Price Forecast by Application (2023-2028)
7 North America
7.1 North America Vinblastinesulphate Market Size by Type
7.1.1 North America Vinblastinesulphate Sales by Type (2017-2028)
7.1.2 North America Vinblastinesulphate Revenue by Type (2017-2028)
7.2 North America Vinblastinesulphate Market Size by Application
7.2.1 North America Vinblastinesulphate Sales by Application (2017-2028)
7.2.2 North America Vinblastinesulphate Revenue by Application (2017-2028)
7.3 North America Vinblastinesulphate Sales by Country
7.3.1 North America Vinblastinesulphate Sales by Country (2017-2028)
7.3.2 North America Vinblastinesulphate Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Vinblastinesulphate Market Size by Type
8.1.1 Europe Vinblastinesulphate Sales by Type (2017-2028)
8.1.2 Europe Vinblastinesulphate Revenue by Type (2017-2028)
8.2 Europe Vinblastinesulphate Market Size by Application
8.2.1 Europe Vinblastinesulphate Sales by Application (2017-2028)
8.2.2 Europe Vinblastinesulphate Revenue by Application (2017-2028)
8.3 Europe Vinblastinesulphate Sales by Country
8.3.1 Europe Vinblastinesulphate Sales by Country (2017-2028)
8.3.2 Europe Vinblastinesulphate Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Vinblastinesulphate Market Size by Type
9.1.1 Asia Pacific Vinblastinesulphate Sales by Type (2017-2028)
9.1.2 Asia Pacific Vinblastinesulphate Revenue by Type (2017-2028)
9.2 Asia Pacific Vinblastinesulphate Market Size by Application
9.2.1 Asia Pacific Vinblastinesulphate Sales by Application (2017-2028)
9.2.2 Asia Pacific Vinblastinesulphate Revenue by Application (2017-2028)
9.3 Asia Pacific Vinblastinesulphate Sales by Region
9.3.1 Asia Pacific Vinblastinesulphate Sales by Region (2017-2028)
9.3.2 Asia Pacific Vinblastinesulphate Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Vinblastinesulphate Market Size by Type
10.1.1 Latin America Vinblastinesulphate Sales by Type (2017-2028)
10.1.2 Latin America Vinblastinesulphate Revenue by Type (2017-2028)
10.2 Latin America Vinblastinesulphate Market Size by Application
10.2.1 Latin America Vinblastinesulphate Sales by Application (2017-2028)
10.2.2 Latin America Vinblastinesulphate Revenue by Application (2017-2028)
10.3 Latin America Vinblastinesulphate Sales by Country
10.3.1 Latin America Vinblastinesulphate Sales by Country (2017-2028)
10.3.2 Latin America Vinblastinesulphate Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vinblastinesulphate Market Size by Type
11.1.1 Middle East and Africa Vinblastinesulphate Sales by Type (2017-2028)
11.1.2 Middle East and Africa Vinblastinesulphate Revenue by Type (2017-2028)
11.2 Middle East and Africa Vinblastinesulphate Market Size by Application
11.2.1 Middle East and Africa Vinblastinesulphate Sales by Application (2017-2028)
11.2.2 Middle East and Africa Vinblastinesulphate Revenue by Application (2017-2028)
11.3 Middle East and Africa Vinblastinesulphate Sales by Country
11.3.1 Middle East and Africa Vinblastinesulphate Sales by Country (2017-2028)
11.3.2 Middle East and Africa Vinblastinesulphate Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Guangzhou Hanfang Pharmaceutical
12.1.1 Guangzhou Hanfang Pharmaceutical Corporation Information
12.1.2 Guangzhou Hanfang Pharmaceutical Overview
12.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Guangzhou Hanfang Pharmaceutical Recent Developments
12.2 Hainan Vinca Biological Medicine Technology
12.2.1 Hainan Vinca Biological Medicine Technology Corporation Information
12.2.2 Hainan Vinca Biological Medicine Technology Overview
12.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Hainan Vinca Biological Medicine Technology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Hainan Vinca Biological Medicine Technology Recent Developments
12.3 Guangzhou Person Pharmaceutical
12.3.1 Guangzhou Person Pharmaceutical Corporation Information
12.3.2 Guangzhou Person Pharmaceutical Overview
12.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Guangzhou Person Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Guangzhou Person Pharmaceutical Recent Developments
12.4 Hainan Yueyang Biotechnology
12.4.1 Hainan Yueyang Biotechnology Corporation Information
12.4.2 Hainan Yueyang Biotechnology Overview
12.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hainan Yueyang Biotechnology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hainan Yueyang Biotechnology Recent Developments
12.5 Hubei Honch Pharmaceutical
12.5.1 Hubei Honch Pharmaceutical Corporation Information
12.5.2 Hubei Honch Pharmaceutical Overview
12.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Hubei Honch Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Hubei Honch Pharmaceutical Recent Developments
12.6 Fine Chemicals Corporation
12.6.1 Fine Chemicals Corporation Corporation Information
12.6.2 Fine Chemicals Corporation Overview
12.6.3 Fine Chemicals Corporation Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Fine Chemicals Corporation Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Fine Chemicals Corporation Recent Developments
12.7 Hengtengfu Biological Products
12.7.1 Hengtengfu Biological Products Corporation Information
12.7.2 Hengtengfu Biological Products Overview
12.7.3 Hengtengfu Biological Products Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Hengtengfu Biological Products Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Hengtengfu Biological Products Recent Developments
12.8 Vinkem
12.8.1 Vinkem Corporation Information
12.8.2 Vinkem Overview
12.8.3 Vinkem Vinblastinesulphate Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Vinkem Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Vinkem Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Vinblastinesulphate Industry Chain Analysis
13.2 Vinblastinesulphate Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Vinblastinesulphate Production Mode & Process
13.4 Vinblastinesulphate Sales and Marketing
13.4.1 Vinblastinesulphate Sales Channels
13.4.2 Vinblastinesulphate Distributors
13.5 Vinblastinesulphate Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Vinblastinesulphate Industry Trends
14.2 Vinblastinesulphate Market Drivers
14.3 Vinblastinesulphate Market Challenges
14.4 Vinblastinesulphate Market Restraints
15 Key Finding in The Global Vinblastinesulphate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Vinblastinesulphate Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of >98% Vinblastinesulphate
Table 3. Major Manufacturers of 97-98% Vinblastinesulphate
Table 4. Major Manufacturers of Other
Table 5. Global Vinblastinesulphate Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Vinblastinesulphate Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 7. Global Vinblastinesulphate Production by Region (2017-2022) & (Kg)
Table 8. Global Vinblastinesulphate Production Market Share by Region (2017-2022)
Table 9. Global Vinblastinesulphate Production by Region (2023-2028) & (Kg)
Table 10. Global Vinblastinesulphate Production Market Share by Region (2023-2028)
Table 11. Global Vinblastinesulphate Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Vinblastinesulphate Sales by Region (2017-2022) & (Kg)
Table 13. Global Vinblastinesulphate Sales Market Share by Region (2017-2022)
Table 14. Global Vinblastinesulphate Sales by Region (2023-2028) & (Kg)
Table 15. Global Vinblastinesulphate Sales Market Share by Region (2023-2028)
Table 16. Global Vinblastinesulphate Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Vinblastinesulphate Revenue Market Share by Region (2017-2022)
Table 18. Global Vinblastinesulphate Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Vinblastinesulphate Revenue Market Share by Region (2023-2028)
Table 20. Global Vinblastinesulphate Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 21. Global Vinblastinesulphate Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Vinblastinesulphate Sales by Manufacturers (2017-2022) & (Kg)
Table 23. Global Vinblastinesulphate Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Vinblastinesulphate Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Vinblastinesulphate Revenue Share by Manufacturers (2017-2022)
Table 26. Vinblastinesulphate Price by Manufacturers 2017-2022 (USD/g)
Table 27. Global Vinblastinesulphate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Vinblastinesulphate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vinblastinesulphate as of 2021)
Table 29. Vinblastinesulphate Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Vinblastinesulphate Product Offered
Table 31. Date of Manufacturers Enter into Vinblastinesulphate Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 34. Global Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 35. Global Vinblastinesulphate Sales Share by Type (2017-2022)
Table 36. Global Vinblastinesulphate Sales Share by Type (2023-2028)
Table 37. Global Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Vinblastinesulphate Revenue Share by Type (2017-2022)
Table 40. Global Vinblastinesulphate Revenue Share by Type (2023-2028)
Table 41. Vinblastinesulphate Price by Type (2017-2022) & (USD/g)
Table 42. Global Vinblastinesulphate Price Forecast by Type (2023-2028) & (USD/g)
Table 43. Global Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 44. Global Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 45. Global Vinblastinesulphate Sales Share by Application (2017-2022)
Table 46. Global Vinblastinesulphate Sales Share by Application (2023-2028)
Table 47. Global Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Vinblastinesulphate Revenue Share by Application (2017-2022)
Table 50. Global Vinblastinesulphate Revenue Share by Application (2023-2028)
Table 51. Vinblastinesulphate Price by Application (2017-2022) & (USD/g)
Table 52. Global Vinblastinesulphate Price Forecast by Application (2023-2028) & (USD/g)
Table 53. North America Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 54. North America Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 55. North America Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 58. North America Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 59. North America Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Vinblastinesulphate Sales by Country (2017-2022) & (Kg)
Table 62. North America Vinblastinesulphate Sales by Country (2023-2028) & (Kg)
Table 63. North America Vinblastinesulphate Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Vinblastinesulphate Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 66. Europe Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 67. Europe Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 70. Europe Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 71. Europe Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Vinblastinesulphate Sales by Country (2017-2022) & (Kg)
Table 74. Europe Vinblastinesulphate Sales by Country (2023-2028) & (Kg)
Table 75. Europe Vinblastinesulphate Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Vinblastinesulphate Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 78. Asia Pacific Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 79. Asia Pacific Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 82. Asia Pacific Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 83. Asia Pacific Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Vinblastinesulphate Sales by Region (2017-2022) & (Kg)
Table 86. Asia Pacific Vinblastinesulphate Sales by Region (2023-2028) & (Kg)
Table 87. Asia Pacific Vinblastinesulphate Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Vinblastinesulphate Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 90. Latin America Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 91. Latin America Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 94. Latin America Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 95. Latin America Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Vinblastinesulphate Sales by Country (2017-2022) & (Kg)
Table 98. Latin America Vinblastinesulphate Sales by Country (2023-2028) & (Kg)
Table 99. Latin America Vinblastinesulphate Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Vinblastinesulphate Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vinblastinesulphate Sales by Type (2017-2022) & (Kg)
Table 102. Middle East and Africa Vinblastinesulphate Sales by Type (2023-2028) & (Kg)
Table 103. Middle East and Africa Vinblastinesulphate Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vinblastinesulphate Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Vinblastinesulphate Sales by Application (2017-2022) & (Kg)
Table 106. Middle East and Africa Vinblastinesulphate Sales by Application (2023-2028) & (Kg)
Table 107. Middle East and Africa Vinblastinesulphate Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Vinblastinesulphate Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Vinblastinesulphate Sales by Country (2017-2022) & (Kg)
Table 110. Middle East and Africa Vinblastinesulphate Sales by Country (2023-2028) & (Kg)
Table 111. Middle East and Africa Vinblastinesulphate Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Vinblastinesulphate Revenue by Country (2023-2028) & (US$ Million)
Table 113. Guangzhou Hanfang Pharmaceutical Corporation Information
Table 114. Guangzhou Hanfang Pharmaceutical Description and Major Businesses
Table 115. Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 116. Guangzhou Hanfang Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Guangzhou Hanfang Pharmaceutical Recent Development
Table 118. Hainan Vinca Biological Medicine Technology Corporation Information
Table 119. Hainan Vinca Biological Medicine Technology Description and Major Businesses
Table 120. Hainan Vinca Biological Medicine Technology Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 121. Hainan Vinca Biological Medicine Technology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Hainan Vinca Biological Medicine Technology Recent Development
Table 123. Guangzhou Person Pharmaceutical Corporation Information
Table 124. Guangzhou Person Pharmaceutical Description and Major Businesses
Table 125. Guangzhou Person Pharmaceutical Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 126. Guangzhou Person Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Guangzhou Person Pharmaceutical Recent Development
Table 128. Hainan Yueyang Biotechnology Corporation Information
Table 129. Hainan Yueyang Biotechnology Description and Major Businesses
Table 130. Hainan Yueyang Biotechnology Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 131. Hainan Yueyang Biotechnology Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Hainan Yueyang Biotechnology Recent Development
Table 133. Hubei Honch Pharmaceutical Corporation Information
Table 134. Hubei Honch Pharmaceutical Description and Major Businesses
Table 135. Hubei Honch Pharmaceutical Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 136. Hubei Honch Pharmaceutical Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Hubei Honch Pharmaceutical Recent Development
Table 138. Fine Chemicals Corporation Corporation Information
Table 139. Fine Chemicals Corporation Description and Major Businesses
Table 140. Fine Chemicals Corporation Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 141. Fine Chemicals Corporation Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Fine Chemicals Corporation Recent Development
Table 143. Hengtengfu Biological Products Corporation Information
Table 144. Hengtengfu Biological Products Description and Major Businesses
Table 145. Hengtengfu Biological Products Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 146. Hengtengfu Biological Products Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Hengtengfu Biological Products Recent Development
Table 148. Vinkem Corporation Information
Table 149. Vinkem Description and Major Businesses
Table 150. Vinkem Vinblastinesulphate Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 151. Vinkem Vinblastinesulphate Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Vinkem Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Vinblastinesulphate Distributors List
Table 156. Vinblastinesulphate Customers List
Table 157. Vinblastinesulphate Market Trends
Table 158. Vinblastinesulphate Market Drivers
Table 159. Vinblastinesulphate Market Challenges
Table 160. Vinblastinesulphate Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Vinblastinesulphate Product Picture
Figure 2. Global Vinblastinesulphate Market Share by Type in 2021 & 2028
Figure 3. >98% Vinblastinesulphate Product Picture
Figure 4. 97-98% Vinblastinesulphate Product Picture
Figure 5. Other Product Picture
Figure 6. Global Vinblastinesulphate Market Share by Application in 2021 & 2028
Figure 7. Lymphoma
Figure 8. Lung Cancer
Figure 9. Breast & Ovarian Cancer
Figure 10. Leukemia
Figure 11. Other
Figure 12. Vinblastinesulphate Report Years Considered
Figure 13. Global Vinblastinesulphate Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 14. Global Vinblastinesulphate Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Vinblastinesulphate Production Market Share by Region (2017-2022)
Figure 16. Global Vinblastinesulphate Production Market Share by Region (2023-2028)
Figure 17. Vinblastinesulphate Production Growth Rate in South Africa (2017-2028) & (Kg)
Figure 18. Vinblastinesulphate Production Growth Rate in India (2017-2028) & (Kg)
Figure 19. Vinblastinesulphate Production Growth Rate in China (2017-2028) & (Kg)
Figure 20. Global Vinblastinesulphate Sales 2017-2028 (Kg)
Figure 21. Global Vinblastinesulphate Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Vinblastinesulphate Revenue 2017-2028 (US$ Million)
Figure 23. Global Vinblastinesulphate Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Vinblastinesulphate Sales Market Share by Region (2017-2022)
Figure 25. Global Vinblastinesulphate Sales Market Share by Region (2023-2028)
Figure 26. North America Vinblastinesulphate Sales YoY (2017-2028) & (Kg)
Figure 27. North America Vinblastinesulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Europe Vinblastinesulphate Sales YoY (2017-2028) & (Kg)
Figure 29. Europe Vinblastinesulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Vinblastinesulphate Sales YoY (2017-2028) & (Kg)
Figure 31. Asia-Pacific Vinblastinesulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 32. Latin America Vinblastinesulphate Sales YoY (2017-2028) & (Kg)
Figure 33. Latin America Vinblastinesulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 34. Middle East & Africa Vinblastinesulphate Sales YoY (2017-2028) & (Kg)
Figure 35. Middle East & Africa Vinblastinesulphate Revenue YoY (2017-2028) & (US$ Million)
Figure 36. The Vinblastinesulphate Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 37. The Top 5 and 10 Largest Manufacturers of Vinblastinesulphate in the World: Market Share by Vinblastinesulphate Revenue in 2021
Figure 38. Vinblastinesulphate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 39. Global Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 40. Global Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 41. Global Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 42. Global Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 43. North America Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 44. North America Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 45. North America Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 46. North America Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 47. North America Vinblastinesulphate Sales Share by Country (2017-2028)
Figure 48. North America Vinblastinesulphate Revenue Share by Country (2017-2028)
Figure 49. U.S. Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 50. Canada Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 51. Europe Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 52. Europe Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 53. Europe Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 54. Europe Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 55. Europe Vinblastinesulphate Sales Share by Country (2017-2028)
Figure 56. Europe Vinblastinesulphate Revenue Share by Country (2017-2028)
Figure 57. Germany Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 58. France Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 59. U.K. Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 60. Italy Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 61. Russia Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 62. Asia Pacific Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 63. Asia Pacific Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 64. Asia Pacific Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 65. Asia Pacific Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 66. Asia Pacific Vinblastinesulphate Sales Share by Region (2017-2028)
Figure 67. Asia Pacific Vinblastinesulphate Revenue Share by Region (2017-2028)
Figure 68. China Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 69. Japan Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 70. South Korea Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 71. India Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 72. Australia Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 73. Taiwan Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 74. Indonesia Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 75. Thailand Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 76. Malaysia Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 77. Philippines Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 78. Latin America Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 79. Latin America Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 80. Latin America Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 81. Latin America Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 82. Latin America Vinblastinesulphate Sales Share by Country (2017-2028)
Figure 83. Latin America Vinblastinesulphate Revenue Share by Country (2017-2028)
Figure 84. Mexico Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 85. Brazil Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 86. Argentina Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 87. Middle East and Africa Vinblastinesulphate Sales Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Vinblastinesulphate Revenue Market Share by Type (2017-2028)
Figure 89. Middle East and Africa Vinblastinesulphate Sales Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Vinblastinesulphate Revenue Market Share by Application (2017-2028)
Figure 91. Middle East and Africa Vinblastinesulphate Sales Share by Country (2017-2028)
Figure 92. Middle East and Africa Vinblastinesulphate Revenue Share by Country (2017-2028)
Figure 93. Turkey Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 94. Saudi Arabia Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 95. U.A.E Vinblastinesulphate Revenue (2017-2028) & (US$ Million)
Figure 96. Vinblastinesulphate Value Chain
Figure 97. Vinblastinesulphate Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed

---